3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
CNS
3
Dermatologic
1
Conditions
Melanoma
2
Glioma
1
Glioblastoma
1
Carcinoma, Merkel Cell
1
Interventions
trametinib
2
dabrafenib
2
binimetinib
2
Trastuzumab
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Cisplatin
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
tipifarnib
1
sapanisertib
1
romidepsin
1
ripretinib
1
relatlimab
1
pertuzumab
1
pembrolizumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
glutathione pegylated liposomal doxorubicin
1
erdafitinib
1
entrectinib
1
entinostat
1
efineptakin alfa
1
durvalumab
1
defactinib
1
copanlisib
1
cobimetinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioma
×
efineptakin alfa
×
Dermatologic
×
Clear all
NCT04289155
2022-03-17
Individual Patient Compassionate Use of GX-I7
Genexine, Inc.
No longer available